These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 9276747

  • 1. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.
    Kavallaris M, Kuo DY, Burkhart CA, Regl DL, Norris MD, Haber M, Horwitz SB.
    J Clin Invest; 1997 Sep 01; 100(5):1282-93. PubMed ID: 9276747
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.
    Kavallaris M, Burkhart CA, Horwitz SB.
    Br J Cancer; 1999 Jun 01; 80(7):1020-5. PubMed ID: 10362110
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of isotype-specific regions of five classes of canine beta-tubulin and their expression in several tissues and cell culture.
    Arai K, Maruo K, Ara KY, Uehara K, Matsuda H.
    J Vet Med Sci; 2001 Dec 01; 63(12):1297-302. PubMed ID: 11789607
    [Abstract] [Full Text] [Related]

  • 9. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
    Parekh H, Wiesen K, Simpkins H.
    Biochem Pharmacol; 1997 Feb 21; 53(4):461-70. PubMed ID: 9105396
    [Abstract] [Full Text] [Related]

  • 10. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
    Nicoletti MI, Valoti G, Giannakakou P, Zhan Z, Kim JH, Lucchini V, Landoni F, Mayo JG, Giavazzi R, Fojo T.
    Clin Cancer Res; 2001 Sep 21; 7(9):2912-22. PubMed ID: 11555610
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SRC tyrosine kinase and multidrug resistance protein-1 inhibitions act independently but cooperatively to restore paclitaxel sensitivity to paclitaxel-resistant ovarian cancer cells.
    George JA, Chen T, Taylor CC.
    Cancer Res; 2005 Nov 15; 65(22):10381-8. PubMed ID: 16288028
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.
    Martello LA, Verdier-Pinard P, Shen HJ, He L, Torres K, Orr GA, Horwitz SB.
    Cancer Res; 2003 Mar 15; 63(6):1207-13. PubMed ID: 12649178
    [Abstract] [Full Text] [Related]

  • 19. Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulins.
    Tommasi S, Mangia A, Lacalamita R, Bellizzi A, Fedele V, Chiriatti A, Thomssen C, Kendzierski N, Latorre A, Lorusso V, Schittulli F, Zito F, Kavallaris M, Paradiso A.
    Int J Cancer; 2007 May 15; 120(10):2078-85. PubMed ID: 17285590
    [Abstract] [Full Text] [Related]

  • 20. Study of multi-drug resistant mechanisms in a taxol-resistant hepatocellular carcinoma QGY-TR 50 cell line.
    Zhou J, Cheng SC, Luo D, Xie Y.
    Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1237-42. PubMed ID: 11162660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.